About this trial
To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
manifest glaucoma, ocular Hypertension, glaucoma suspect
Disqualifiers
under 18 years of age, corneal diseases
Trial population
Glaucoma patients attending a tertiary University Hospital glaucoma Service.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Follow-up intervals
To find the best follow-up intervals for glaucoma patients.
Secondary outcomes
Assessment of treatment quality
What is the best treatment option for the individual patient?
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy
Diurnal intraocular pressure, best corrected visual acuity, visual fields
Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery
Diurnal intraocular pressure, best corrected visual acuity, visual fields
Sponsors and contacts
Click on the lead sponsor to view all of their trials.